In HCC, TRAF2 also promotes tumor growth by preventing ROS production, mitochondrial dysfunction [109] and autophagy [110] and contributes to drug resistance by supporting ER stress response [111]. This evidence concerns the gene TRAF2 and hepatocellular carcinoma.